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pen accessAbstract Background: Endotracheal mechanical ventilation (ETMV) is accompanied with a high
morbidity and mortality in intensive care unit (ICU) patients. The aim of this prospective random-
ized controlled study was to evaluate the effectiveness of noninvasive proportional assist ventilation
(PAV) as a method of weaning in patients who could not tolerate spontaneous breathing trial
(SBT).
Patients and methods: Among 112 patients presented with acute respiratory failure (ARF) admitted
to Zagazig university surgical ICU, 42 patients of them failed a 2 h-SBT after they met simple cri-
teria for weaning. Conventional invasive synchronized intermittent mandatory ventilation (SIMV)
was used as the control weaning technique in 21 patients (SIMV group), and noninvasive PAV was
applied immediately after extubation in the remaining 21 patients (PAV group).
Results: There was no signiﬁcant difference regarding the main clinical, functional characteristics,
and the physiologic parameters of the two weaning groups at the time of their admission. Gas
exchange at 1-h post-randomisation was signiﬁcantly improved in both groups. The duration of
ventilatory support was signiﬁcantly shorter in the PAV group (12.8 + 8.3 days vs 22.3 + 13.3 days
in the conventional group; P< 0.05). Weaning success was signiﬁcantly higher in the PAV group
(18 patients‘‘85%’’ vs 11 patients ‘‘52 %’’ in the conventional group P< 0.05). ICU survival was
higher, while, reintubation rate was lower in PAV (three patients ‘‘14%’’ vs 10 patients ‘‘47%’’ inzig University Hospital, Borg
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90 M.M. Tawfeek, A.M. Ali Elnabtitythe conventional group; P< 0.05). The rate of tracheostomy was signiﬁcantly lower in the PAV
group (one patient ‘‘4%’’ vs seven patients ‘‘33%’’ in the conventional group; P< 0.05). The inci-
dence of VAP was higher in the conventional group (eight patients ‘‘38%’’ vs one patient ‘‘4%’’in
the PAV group; P< 0.05).
Conclusion: Noninvasive PAV could be considered as an effective and safe method of weaning in
patients who cannot tolerate 2 h-SBT.
ª 2011 Egyptian Society of Anesthesiologists. Production and hosting by Elsevier B.V.
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ETMV has been shown to be used successfully in patients pre-
sented with respiratory failure. Once the underlying indication
of respiratory failure has been reversed, the majority of these
patients can be abruptly discontinued after tolerating a
2 h-SBT [1]. However, up to 30% of those patients fail this
SBT, denoting difﬁcult weaning [2]. The causes of weaning fail-
ure in those populations should be reviewed, corrected, and
screening for weanability should be attempted once daily using
SBT [1].
However, persistent weaning failure is associated with pro-
longed MV [3] and increased risk of VAP, prolonged ICU stay,
and mortality [4].
Therefore, any intervention aiming at shortening the wean-
ing period should be encouraged.
Prophylactic noninvasive ventilation (NIV) has been used
effectively to prevent respiratory failure after tracheal extuba-
tion and reduced ICU mortality in patients at risk for postex-
tubation complications [5,6]. However the role of NIV in
established postextubation respiratory failure is lacking [7,8].
On the other hand, NIV was used to facilitate weaning of
patients who did not tolerate SBT in previous uncontrolled
[9–11], and randomized controlled studies [12–15], as well as
meta- analysis [16]. Most patients had COPD in these trials.
To our knowledge, there is only one study evaluated the role
of NIV in patients with respiratory failure due to other causes
[17].
Bi-level positive airway pressure (BIPAP) was selected as
the noninvasive modality among the majority of these trials.
The efﬁcacy of PAV, a relatively recent partial ventilator sup-
port mode, in this relatively frequent clinical situation has not
been assessed as yet.
The aim of the study was to evaluate noninvasive PAV as a
new method of weaning in selected populations of patients
who met simple weaning criteria but failed 2 h- SBT. End
points of the study were duration of ventilatory support, inci-
dence of VAP, reintubation rate, and 30-day survival rate.
2. Patients and methods
This study included adult patients who were admitted consec-
utively to our 14-bed surgical ICU from July 2008 to July 2010
and were presented with ARF requiring ETMV for more than
48 h. The study was approved by the local ethical Committee,
and written informed consent form was obtained by a family
member for each patient.
Patients with facial trauma, recent gastric or esophageal
surgery, tracheotomy, excessive respiratory secretion, lack of
co-operation, or active upper gastrointestinal bleeding were
excluded from the study.A SBT was initiated once: the patient was afebrile and fully
conscious with no need of sedation, and fulﬁlled the following
criteria: reversal or some reversal of the cause of ARF that
indicate ventilation support, adequate oxygenation (arterial
partial pressure of oxygen (PaO2) of >60 mm Hg on fraction
of inspired oxygen (FiO2) of 60.4, and positive end-expiratory
pressure (PEEP) of 65 cm H2O during pressure support venti-
lation (PSV) 6 8 mm Hg), and hemodynamic stability(systolic
blood pressureP 90 mm Hg, heart rate 6 120 beats/min with-
out vasopressors). At The end of the ﬁrst minute of the SBT,
patients were screened for readiness to wean using rapid shal-
low breathing index (RSBI); respiratory rate in 1 min divided
by the average tidal volume (VT) in the same minute (R/
TV). If it was <105, patients were considered ready to wean
and SBT was extended for another 2 h.
If patients tolerate a 2 h SBTs, patients were extubated and
excluded from the study. SBT was considered to be failed if:
peripheral oxygen saturation (SPO2) measured by pulse oxim-
etry of <90% (80% in chronic respiratory failure), respiratory
rate (f)P 35 breath/min, heart rate (HR) of >140 or <50 -
beats/min (or increase or decrease of >20% in previous
MV), and systolic arterial blood pressure of >180 mm Hg
or <70 mm Hg (or increase or decrease of >20% in previous
MV) and RSBI > 105 or increased work of breathing sug-
gested by the use of accessory respiratory muscles, paradoxical
motion of the abdomen, or retraction of the intercostal spaces.
Patients who failed the SBT were randomally allocated into
two groups. Patient in the ﬁrst group were fully supported
through SIMV mode using Servo I ventilator (SIMV group).
While patients in the other group were extubated and NIV
was established immediately through PAV mode (PAV group).
Random assignment was done by using opaque, sealed, num-
bered envelopes.
In the control SIMV group, ventilatory parameters were ad-
justed till the previous PaCO2 and pH values were reached
within the ﬁrst 60 min and the respiratory rate was 630 -
breaths/min In the PAV group, both ﬂow and volume assist
PAV were adjusted separately using ‘‘Runaway’’ phenomena.
Runaway occurs when the pressure applied by the ventilator ex-
ceeds the opposing elastic and resistive pressure at the end of
patient inspiration, and then ﬂow and volume continue to be
delivered by the ventilator during the patient’s neural expira-
tion increasing airway pressure during expiration [18–20]. Flow
assist (FA) was set at 1 cm H2O L
1 s1 whereas volume assist
(VA) was set at 2 cm H2O L
1, then VA was raised in steps of
2 cm H2O L
1 until the ‘‘run-away’’ phenomenon occurred,
then FA was raised in steps of 1 cm H2O L
1 s1 until the
‘‘run-away’’ phenomenon occurred. The values of the FA at
the ‘‘run-away’’ minus 1 cm H2O L
1 s1, and VA at the
‘‘run-away’’ minus 2 cm H2O L
1 were assumed to reﬂect pa-
tients’ ﬂow resistances, and volume elastance respectively [21].
Table 1 Patients characteristics.
PAV group
(n= 21)
SIMV group
(n= 21)
Age (years) 71 ± 9 70 ± 10
Sex (M/F) 15/5 13/7
APPACHE II on admission 21 ± 5 20 ± 7
APPACHE II on entry into study 13 ± 4 13 ± 5
Indication of MV (n)
Acute exacerbation of COPD 5 4
Acute pulmonary edema 3 3
Community acquired pnemonia 3 4
Postoperative respiratory failure 4 4
Thoracic trauma 3 1
Postcardiac arrest 1 2
Neuromuscular disorders 2 3
Values are presented as mean ± SD or number (percentage).
PAV= Proportional assisted ventilation. SIMV= Synchronized
intermittent mandatory ventilation. APACHE-II = Acute physi-
ology and chronic health evaluation-II score.
Table 2 Physiologic parameters at admission.
PAV group
(n= 21)
SIMV group
(n= 21)
F (breath/min) 37 ± 8 34 ± 11
Heart rate (beat/min) 112 ± 23 113 ± 26
Systolic blood pressure (mm Hg) 142 ± 28 140 ± 32
Arterial pH 7.26 ± 0.08 7.26 ± 0.09
PaCO2 (mm Hg) 116 ± 66 117 ± 59
PaO2 (mm Hg) 44.6 ± 9.5 47.0 ± 6.6
Values are presented as mean ± SD. F= Frequency.
PAV= Proportional assisted ventilation. SIMV= Synchronized
intermittent mandatory ventilation. PaCO2 = arterial carbon
dioxide tension. PaO2 = Arterial oxygen tension.
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for expectoration by means of a prototype portable ventilator
(Respironics, Murrysville, PA, USA), through a full face mask
(Respironics, Murrysville, PA, USA) with adequate size for
each patient. Reintubation was performed immediately if when
any of the following events occurred: hypercapnia (arterial
pH < 7.35 with an increase in carbon dioxide arterial tension
(Pa, CO2) of >20% from the time of extubation), hypoxemia
(SPO2 by pulse oximetry of <90% with FiO2 of 0.5, decreased
consciousness rendering the patient unable to tolerate NIV,
clinical signs suggestive of respiratory muscle fatigue and/or
increased work of breathing as described above, inability to
clear secretions, and severe haemodynamic instability without
response to ﬂuids and vasopressors.
Gradual withdrawal of ventilator support was performed in
the PAV group, while SBT was done once daily in the conven-
tional weaning group till patients can tolerate spontaneous
breathing.
The patient’s clinical and demographic characteristics were
recorded on admission. The primary evaluation criteria were
success of weaning (deﬁned as the absence of reintubation
within 3 days after extubation. Duration of MV (from the
day of intubation to the day of extubation from the artiﬁcial
airway before randomization plus weaning duration after ran-
domization in the control group, and before randomization in
the PAV group) was also measured. The other evaluation cri-
teria were survival rate at 30 days, and complications related to
ETMV and/or weaning procedure as septic shock, pnemotho-
rax, and VAP.
VAP was deﬁned as the presence of a new and persistent
(>48 h) lung inﬁltrate on chest X-ray combined with at least
two of the following conditions: fever, peripheral leukocyte
count >10000 cells/mm3, and endotracheal secretion obtained
by suctioning from lower respiratory tract in which a Gram
stain showed one or more types of bacteria [12].
Tracheotomy was performed 14 days from initiation of ven-
tilatory support according to our ICU protocol.
3. Statistical analysis
Data are presented as mean ± SD or percentage. Comparison
of two means was performed using the Student test. Compari-
son of percentages was performed using the Fisher exact meth-
od. P value < 0.05 was considered signiﬁcant.
4. Results
Throughout the study period, 112 patients required ETMV for
more than 48 h in our ICU, 65 patients were candidate for
weaning. Twenty-three patients tolerated a SBT and were ex-
cluded from the study. The remaining 42 patients failed a
2 h-SBT after they met simple criteria for weaning. These pa-
tients were randomized into PAV group (21 patients) and con-
ventional SIMV weaning group (21 patients).
No signiﬁcant difference regarding the main clinical and
functional characteristics of the two weaning groups at the
time of their admission (Table 1). There were also no signiﬁ-
cant differences in the physiologic parameters of patients on
the day of randomization between the two groups including
the breathing pattern, heart rate, systolic blood pressure, and
arterial blood gases (Table 2). Gas exchange variables mea-
sured 1-h post randomization were comparable in both groups
(Table 3).Compared with the control group, the duration of ventila-
tory support was shorter in the PAV group (12.8 ± 8.3 days vs
22.3 ± 13.3 days in the conventional group; P=<0.05). The
success rate among patients weaned with invasive SIMV was
signiﬁcantly lower than the rate among patients undergoing
noninvasive PAV (11 patients ‘‘52%’’ vs 18 patients ‘‘85%’’
in the PAV group; P< 0.05). The incidence of reintubation
was signiﬁcantly lower in the PAV group (three ‘‘14%’’
patients’ vs 10 ‘‘47%’’ patients in the conventional weaning
group; P< 0.05). Causes of renitubation were presented in
Table 4.
One patient ‘‘4%’’ from the PAV group tracheotomized vs
seven ‘‘33%’’ patients in the conventional-weaning group <0.
05). Compared with patients weaned conventionally, mortality
rate at 30 days after admission was higher in the PAV group
(19 patients’ vs 15 patients in the conventional weaning group)
(Table 4).
The incidence of VAP was higher in the SIMV weaning
group (eight patients ‘‘38%’’ vs one patient ‘‘4%’’ in the
PAV group; P< 0.05) (Table 5). The complications related
to noninvasive PAV were limited to mild to moderate nasal
bridge ulceration occurred in three Patients, and respiratory
secretions were difﬁcult to eliminate in two patients.
Table 3 Effects of weaning technique on gas exchange.
2 h-SBT 1-h Post-randomization
Control group (n = 21)
PaO2 (mmHg) 72.27 ± 9.29 88.26 ± 17.22
PaCO2 (mmHg) 56.14 ± 9.33 45 ± 10.90
pH 7.28 ± 0.08 7.36 ± 0.05
PAV group (n = 21)
PaO2 (mmHg) 74.37 ± 8.15 89.8 ± 9.92
PaCO2 (mmHg) 55.68 ± 9.84 46.13 ± 11.10
pH 7.24 ± 0.11 7.35 ± 0.10
Values are presented as mean ± SD PAV= proportional assisted
ventilation.
2 h-SBT= Gas exchange variables at the end of 2 h-spontaneous
breathing trial.
1-h Post-randomization = Gas exchange variable 1-h from ran-
domization in both groups.
Table 5 Recorded complications.
PAV group (n= 21) SIMV group (n= 21)
VAP 1 (4%) 8 (38%)*
Bed sores – 2 (9%)
PE 1 (4%) 2 (9%)
GIT bleeding 1 (4%) 2 (9%)
Pneumothorax – 1 (4%)
Septic shock 1 (4%) 4 (19%)
Values presented as number (percentage). VAP = Ventilator
associated pneumonia. GIT = Gastrointestinal. PE = Pulmonary
embolism. PAV= Proportional assisted ventilation.
SIMV= Synchronized intermittent mandatory ventilation.
* P=<0.05.
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ETMV is considered a live saving intervention for patients
treated from respiratory failure; however it is associated with
undesirable side effects and life-threatening complications [22].
Our ICU weaning protocol includes daily SBT after testing
of patients who met simple weaning criteria for weaning read-
iness. This daily SBT has been shown to reduce the time spent
on MV and the reintubation rate [23]. However, many patients
fail these SBTs and suffer difﬁcult weaning. We tested the abil-
ity of integrating the role of NIV in our weaning protocol in
selected population of these patients.
The most important ﬁnding of this study was that, for pa-
tients who had no contraindications for NIV and met simple
weaning criteria but failed SBT, the combination of earlier tra-
cheal extubation and initiation of noninvasive PAV had been
associated with shorter duration of ventilatory support, lower
incidence of VAP, and better ICU survival.
The shorter duration of ventilatory support encountered in
the PAV group, and weaning process was similar to the studies
of Nava et al. [12] and Ferrer et al. [14], however in Girault et al.
[13] study, the daily ventilator duration was higher in the NIV
and hospital stay was insigniﬁcantly different between the two
groups that may be explained by the different patient character-Table 4 Weaning outcome variables.
PAV group
(n= 21)
SIMV group
(n= 21)
Duration of ventilator support (days) 12.8 ± 8.3 22.3 ± 13.3*
Success rate, n (%) 18 (85%) 11 (52%)*
Reintubation, n (%) 3 (14%) 10 (47%)*
Causes of reintubation (n)
Severe persistent hypoxemia 0 3
Severe dyspnea 0 3
Inability to manage secretions 2 0
Hemodynamic instability 1 0
Tracheotomy, n (%) 1 (4%) 7 (33%)*
ICU survival at 60 days, n (%) 19 15
Values are presented as mean ± SD or number (percentage).
PAV= Proportional assisted ventilation. SIMV= Synchronized
intermittent mandatory ventilation.
* P=<0.05.istics in the study of Girault that included a higher incidence of
chronic patients who in more need for ventilatory support.
Although, previous studies did not recommend the use of
NIV to extubate non-COPD patients who fail SBT [24]. In this
study, weaning success was signiﬁcantly higher in noninvasive
PAV group patients that was in accordance with Nava et al.
[12]. The high success rate of weaning in PAV group could be ex-
plained by thewell established protocol forNIV in our ICU, and
well trained staff in management of this variety of ventilation.
However, themain cause of successmay be due to the immediate
establishment of noninvasive PAV, a relatively recent synchro-
nized partial ventilatory support that generates a proportional
pressure to the patient’s instantaneous effort [25].
The higher success rate in the PAV group had been associ-
ated with improved survival however it was not signiﬁcant.
Both had been attributed to the less incidence of VAP due to
limiting the period of invasive ventilation, less incidence of
reintubation and tracheostomy in this group.
The better ICU survival in the noninvasive group was in
accordance with and Girault et al. [13] and Ferrer et al. [14].
Nava et al. [12] showed no signiﬁcant differences in the sur-
vival between the two groups in their study that may be ex-
plained by the insigniﬁcant differences in the complications
related to ETI and weaning process between the two groups
speciﬁcally VAP.
The complications encountered in this study are compara-
ble to those of Nava and colleagues [12] and Ferrer and col-
leagues [14]. The authors in these studies used NIV
immediately and continuously after tracheal extubation. On
the other hand, Girault and colleagues [13] used intermittent
NIV and did not observe any signiﬁcant differences in the inci-
dence of complications.
Reintubation is a potentially hazardous complication asso-
ciated with increased morbidity and mortality in mechanically
ventilated patients [24].
The incidence of reintubation was signiﬁcantly lower in the
PAVgroup in the current study; this parameter was studied only
in the study of Nava et al. [12]. In their study, there was no sig-
niﬁcant difference in the incidence of reintubation between non-
invasive and conventional groups. The cause may be due to
initiation of NIV in the conventional-weaning group if other
minor criteria of spontaneous breathing failure occurred.
The higher incidence of VAP in the conventional weaning
group in our study was supported by other studies [26,27].
Previous studies showed that complications related to ETMV
that prolong ventilatory support are essentially related to
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has been shown to be associated with the development of
pneumonia by impairing cough and mucociliary clearance
through accumulation of the contaminated oropharyngeal
secretions above the cuff and leak around the cuff and promot-
ing their colonization [28]. In addition, with NIV, there is a
small possibility of aspiration of colonized oropharyngeal
secretions, there is no airway device, and the patient have
the ability to expectorate [29].
The risk for feeding aspiration increased also with invasive
ventilatory support, Elpern and coworkers [30] showed that
feeding aspiration was found in 50% of tracheotomized pa-
tients receiving prolonged MV. On the other hand, NIV
enables patients to eat avoiding the hazards of food aspiration.
In addition, these patients often are not in need for nasogastric
enteral feeding that has been correlated with a high incidence
of gastroesophageal reﬂux and aspiration [31–33], a major risk
factor for nosocomial pneumonia.
Among the limitations of this study, there was no long-term
follow up of both study groups. Cost evaluation was not also
included in the trial.
In conclusion, Noninvasive PAV could be added safely and
effectively in the MV weaning protocol for patients who meet
simple weaning criteria and but failed SBT and have no con-
traindications to NIV.References
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